Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)

Journal of Infectious Diseases

Volumn 185, Issue 4, 2002, Pages 497-502

  Jiang, Zhi Dong ^a   Lowe, Brett ^c   Verenkar, M P ^d   Ashley, David ^e   Steffen, Robert ^f   Tornieporth, Nadia ^g   Von Sonnenburg, Frank ^h   Waiyaki, Peter ^c   DuPont, Herbert L ^a,b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d GOA MEDICAL COLLEGE   (India)

^e Ministry of Health   (Jamaica)

^f UNIVERSITY OF ZURICH   (Switzerland)

^g GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^h UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; FURAZOLIDONE; GENTAMICIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; SULFAFURAZOLE; TRIMETHOPRIM;

ARTICLE; BACTERIUM ISOLATION; DISEASE SEVERITY; ESCHERICHIA COLI; HUMAN; INDIA; JAMAICA; KENYA; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SHIGELLA; TRAVELLER DIARRHEA;

BACTERIA; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; HUMANS; INDIA; INTESTINES; JAMAICA; KENYA; PREVALENCE; SHIGELLA; TRAVEL;

EID: 0037083098     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/338834     Document Type: Article

References (24)

1. Trimethoprim/sulfamethoxazole remains active against enterotoxigenic Escherichia coli and Shigella spp. in Guadalajara, Mexico
2. Travelers' diarrhea and toxigenic Escherichia coli
3. Epidemiology of travelers' diarrhea and relative importance of various pathogens
4. Travelers' diarrhea: Approaches to prevention and treatment
5. Human rotavirus in an adult population with travelers' diarrhea and its relationship to the location of food consumption
6. Cryptosporidiosis associated with traveling and giardiasis
7. An algae-like organism associated with an outbreak of prolonged diarrhea among foreigners in Nepal
8. Risk and aetiology of diarrhea at various tourist destinations
9. Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica
10. Utility of oligodeoxyribonucleotide probes for detecting enterotoxigenic Escherichia coli
11. Colonization factors of enterotoxigenic Escherichia coli isolated from children with diarrhea in Argentina
12. Improved detection of enterotoxigenic Escherichia coli among patients with travelers' diarrhea by use of the polymerase chain reaction technique
13. Seasonal variation in etiology of travelers' diarrhea
14. Enteroaggregative Escherichia coli as a major etiologic agent in travelers' diarrhea in 3 regions of the world
15. Infection with colonization factor antigen I-expressing enterotoxigenic Escherichia coli boosts antibody responses against heterologous colonization factors in primed subjects
16. Development of oral vaccines against enterotoxigenic Escherichia coli diarrhea
17. Prevention of travelers' diarrhea by oral B-subunit/whole-cell cholera vaccine
18. Vaccines against enterotoxigenic Escherichia coli infections: Oral inactivated vaccines against enterotoxigenic Escherichia coli
19. Enterotoxigenic Escherichia coli in a population of infants with diarrhea in Chile
20. Surveys of human enterotoxigenic Escherichia coli from three different geographical areas for possible colonization factors
21. Ciprofloxacin-resistant Salmonella typhi and treatment failure
22. Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent
23. Antibiotics resistance trends in enteropathogenic bacteria isolated in 1985-1987 and 1995-1998 in Barcelona